Vesencumab

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameVesencumab

Drug Alias NameAnti-NRP1MNRP-1685-AR-7347RG-7347M-1685-A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human

Mechanisms of ActionNeuropilin-1 inhibitors

TargetsNeuropilin-1

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesGenentech Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesGenentech Inc

Active IndicationsN/A

Inactive IndicationsSolid tumours

ATC CodeN/A